J9215 – Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9215
- Long description
- Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
- Short description
- Interferon alfa-n3 inj
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 1993
- Last change
- January 1, 2009 – No change
Frequently asked questions
What is HCPCS code J9215?
J9215 is a HCPCS Level II code for injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu.
Does Medicare cover J9215?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9207 – Injection, ixabepilone, 1 mg
- J9208 – Injection, ifosfamide, 1 gram
- J9209 – Injection, mesna, 200 mg
- J9210 – Injection, emapalumab-lzsg, 1 mg
- J9211 – Injection, idarubicin hydrochloride, 5 mg
- J9212 – Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213 – Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214 – Injection, interferon, alfa-2b, recombinant, 1 million units
- J9216 – Injection, interferon, gamma 1-b, 3 million units
- J9217 – Leuprolide acetate (for depot suspension), 7.5 mg
- J9218 – Leuprolide acetate, per 1 mg
- J9219 – Leuprolide acetate implant, 65 mg
- J9220 – Injection, indigotindisulfonate sodium, 1 mg
- J9223 – Injection, lurbinectedin, 0.1 mg
- J9225 – Histrelin implant (vantas), 50 mg
- J9226 – Histrelin implant (supprelin la), 50 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.